PPARγ signaling and emerging opportunities for improved therapeutics

S Wang, EJ Dougherty, RL Danner - Pharmacological Research, 2016 - Elsevier
Peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand-activated nuclear
receptor that regulates glucose and lipid metabolism, endothelial function and inflammation …

[HTML][HTML] Modulation of gut microbiota composition by serotonin signaling influences intestinal immune response and susceptibility to colitis

YH Kwon, H Wang, E Denou, JE Ghia, L Rossi… - Cellular and molecular …, 2019 - Elsevier
Background & Aims Serotonin (5-hydroxytryptamine [5-HT]) is synthesized mainly within
enterochromaffin (EC) cells in the gut, and tryptophan hydroxylase 1 (Tph1) is the rate …

Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension

T Bertero, Y Lu, S Annis, A Hale, B Bhat… - The Journal of …, 2014 - Am Soc Clin Investig
Development of the vascular disease pulmonary hypertension (PH) involves disparate
molecular pathways that span multiple cell types. MicroRNAs (miRNAs) may coordinately …

Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer

G Mao, Y Liu, XI Fang, Y Liu, L Fang, L Lin, X Liu… - Angiogenesis, 2015 - Springer
Angiogenesis, a crucial step in tumor growth and metastasis, is regulated by various pro-or
anti-angiogenic factors. Recently, microRNAs have been shown to modulate angiogenic …

The microRNA-130/301 family controls vasoconstriction in pulmonary hypertension

T Bertero, K Cottrill, A Krauszman, Y Lu, S Annis… - Journal of Biological …, 2015 - ASBMB
Pulmonary hypertension (PH) is a complex disorder, spanning several known vascular cell
types. Recently, we identified the microRNA-130/301 (miR-130/301) family as a regulator of …

Therapy for pulmonary arterial hypertension: Glance on nitric oxide pathway

A Tettey, Y Jiang, X Li, Y Li - Frontiers in pharmacology, 2021 - frontiersin.org
Pulmonary arterial hypertension (PAH) is a severe disease with a resultant increase of the
mean pulmonary arterial pressure, right ventricular hypertrophy and eventual death …

[HTML][HTML] MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy

X Hou, J Tian, J Geng, X Li, X Tang, J Zhang, X Bai - Oncotarget, 2016 - ncbi.nlm.nih.gov
Abstract MicroRNA-27a (miR-27a) upregulation has been identified in diabetes, but the
pathogenesis of miR-27a in renal tubulointerstitial fibrosis (TIF) in diabetic nephropathy (DN) …

Genetic delivery and gene therapy in pulmonary hypertension

N Rai, M Shihan, W Seeger, RT Schermuly… - International Journal of …, 2021 - mdpi.com
Pulmonary hypertension (PH) is a progressive complex fatal disease of multiple etiologies.
Hyperproliferation and resistance to apoptosis of vascular cells of intimal, medial, and …

Activation of the metabolic master regulator PPARγ: a potential PIOneering therapy for pulmonary arterial hypertension

G Hansmann, L Calvier, MG Risbano… - American journal of …, 2020 - atsjournals.org
Translational research is essential to the development of reverse-remodeling strategies for
the treatment of pulmonary vascular disease, pulmonary hypertension, and heart failure via …

PPARγ ligands attenuate hypoxia-induced proliferation in human pulmonary artery smooth muscle cells through modulation of microRNA-21

DE Green, TC Murphy, BY Kang, CD Searles, CM Hart - PloS one, 2015 - journals.plos.org
Pulmonary hypertension (PH) is a progressive and often fatal disorder whose pathogenesis
involves pulmonary artery smooth muscle cell (PASMC) proliferation. Although modern PH …